🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/10/2014 | 31,12 | 31,86 | 30,88 | 31,34 | +0,34% | 3,15% | 569.546 |
| 17/10/2014 | 30,95 | 31,26 | 29,68 | 31,24 | +2,48% | 5,10% | 776.333 |
| 16/10/2014 | 28,45 | 31,12 | 28,45 | 30,48 | +5,57% | 9,36% | 795.569 |
| 15/10/2014 | 28,14 | 29,14 | 28,14 | 28,87 | +0,98% | 3,55% | 608.980 |
| 14/10/2014 | 28,22 | 29,08 | 27,59 | 28,59 | +2,34% | 5,26% | 706.442 |
| 13/10/2014 | 27,62 | 28,39 | 27,00 | 27,94 | +0,77% | 5,04% | 680.794 |
| 10/10/2014 | 26,72 | 28,73 | 26,72 | 27,72 | +4,91% | 7,52% | 1.185.419 |
| 09/10/2014 | 27,21 | 27,47 | 26,19 | 26,43 | -3,04% | 4,68% | 665.886 |
| 08/10/2014 | 27,80 | 28,00 | 26,70 | 27,26 | +1,82% | 4,69% | 925.091 |
| 07/10/2014 | 27,55 | 27,90 | 26,75 | 26,77 | -3,79% | 4,17% | 521.135 |
| 06/10/2014 | 28,38 | 29,05 | 27,64 | 27,82 | -1,89% | 4,97% | 322.363 |
| 03/10/2014 | 28,88 | 29,38 | 28,03 | 28,36 | -0,57% | 4,69% | 691.534 |
| 02/10/2014 | 28,39 | 28,76 | 27,74 | 28,52 | +0,40% | 3,58% | 520.334 |
| 01/10/2014 | 29,38 | 29,63 | 28,15 | 28,41 | -3,09% | 5,05% | 722.312 |
| 30/09/2014 | 29,63 | 29,97 | 28,90 | 29,31 | -1,30% | 3,62% | 910.825 |
| 29/09/2014 | 29,53 | 30,14 | 29,01 | 29,70 | -0,65% | 3,82% | 722.472 |
| 26/09/2014 | 30,44 | 30,49 | 29,45 | 29,89 | -0,81% | 3,40% | 631.742 |
| 25/09/2014 | 31,19 | 31,60 | 29,81 | 30,14 | -3,55% | 5,72% | 730.167 |
| 24/09/2014 | 29,31 | 31,48 | 29,31 | 31,25 | +6,60% | 7,41% | 691.534 |
| 23/09/2014 | 29,82 | 30,66 | 29,27 | 29,31 | -2,27% | 4,64% | 725.518 |
| 22/09/2014 | 30,24 | 30,38 | 29,34 | 29,99 | -1,35% | 3,45% | 1.259.317 |
| 19/09/2014 | 31,77 | 32,08 | 30,15 | 30,41 | -4,04% | 6,09% | 1.681.226 |
| 18/09/2014 | 32,08 | 32,45 | 31,35 | 31,68 | -0,66% | 3,42% | 589.904 |
| 17/09/2014 | 31,83 | 32,24 | 31,10 | 31,90 | +0,55% | 3,57% | 478.816 |
| 16/09/2014 | 31,32 | 31,85 | 30,45 | 31,72 | +0,83% | 4,46% | 803.424 |
| 15/09/2014 | 32,60 | 32,60 | 31,21 | 31,46 | -3,87% | 4,25% | 300.563 |
| 12/09/2014 | 33,29 | 33,57 | 32,36 | 32,73 | -1,69% | 3,64% | 503.823 |
| 11/09/2014 | 32,65 | 33,33 | 32,50 | 33,29 | +0,98% | 2,52% | 772.967 |
| 10/09/2014 | 30,96 | 33,06 | 30,96 | 32,96 | +6,51% | 6,79% | 676.145 |
| 09/09/2014 | 32,46 | 32,50 | 30,75 | 30,95 | -4,65% | 5,38% | 591.988 |